VKTX

Viking Therapeutics INC

-$230.7M

Net Activity

Institutions Holding

411

Popularity Rank

#1405

Avg Weight

0.11%

Total Value

$2.7B

Ownership Trend

411 institutions currently hold VKTX, with 206 net buyers and 197 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

197

Net Buying Institutions

206

Key Holders

View all 411 holding institutions

Quarterly Activity

Recent Activity

+$1.2B

Total Buy Value

$1.7B

Total Sell Value

New buy53
Trim125
Add153
Sold out72

206

Net Buyers

197

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding VIKING THERAPEUTICS INC (VKTX)?
Major stakeholders currently include BlackRock, Inc. ($223.9M), FMR LLC ($196.0M), Vanguard Capital Management LLC ($163.1M). Based on the latest 13F filings, there are a total of 411 tracked investment funds and institutions maintaining positions in VKTX.
What is the overall institutional sentiment toward VKTX recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $230.7M, driven by 206 managers accumulating shares while 197 reduced their exposure.
Which institutions have been selling or reducing their VKTX positions?
In the latest period, 125 funds trimmed their holdings, and 72 managers completely exited their positions. The aggregate reported sell value was $1.7B.
Are there any notable investors adding VKTX to their portfolios?
Yes, buying activity remains notable. 53 institutions opened new positions in {ticker}, and 153 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.2B.

Related Stocks